New approaches in the management of heart failure.
D001024:Aortic Valve Stenosis / Q000503:physiopathology; D002302:Cardiac Output; D002307:Cardiography, Impedance; D009202:Cardiomyopathies / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002319:Cardiovascular System / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008946:Mitral Valve Stenosis / Q000503:physiopathology; D009200:Myocardial Contraction; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D013318:Stroke Volume; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D009599:Nitroprusside; D011224:Prazosin; D010646:Phentolamine